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ABSTRACT
DNA methylation, the only known covalent modifi-
cation of mammalian DNA, occurs primarily in CpG
dinucleotides. 51% of CpGs in the human genome
reside within repeats, and 25% within Alu elements.
Despite that, no method has been reported for
large-scale ascertainment of CpG methylation in
repeats. Here we describe a sequencing-based
strategy for parallel determination of the CpG-
methylation status of thousands of Alu repeats,
and a computation algorithm to design primers
that enable their specific amplification from bisulfite
converted genomic DNA. Using a single primer
pair, we generated amplicons of high sequence
complexity, and derived CpG-methylation data
from 31178 Alu elements and their 5’ flanking
sequences, altogether representing over 4Mb of a
human cerebellum epigenome. The analysis of the
Alu methylome revealed that the methylation level of
Alu elements is high in the intronic and intergenic
regions, but low in the regions close to transcription
start sites. Several hypomethylated Alu elements
were identified and their hypomethylated status
verified by pyrosequencing. Interestingly, some
Alu elements exhibited a strikingly tissue-specific
pattern of methylation. We anticipate the amplicons
herein described to prove invaluable as epigenome
representations, to monitor epigenomic alterations
during normal development, in aging and in dis-
eases such as cancer.
INTRODUCTION
DNA methylation has been associated with the control of
gene expression, genomic imprinting and the maintenance
of genome integrity (1,2). Dynamic changes in genome-
wide methylation occur during development, aging and
cancer progression (3). For many tissues, the percentage
of 5-methylcytosine in the genome, and in repetitive DNA
particularly, decreases over time. Such loss of DNA
methylation was shown to be age-related (4,5). Although
the functional aspects of age-related genome demethyla-
tion are still largely unclear, such a decrease in the
genome-wide level of DNA methylation has been asso-
ciated with genomic instability (5–7). In addition,
genome-wide hypomethylation has been recognized as
a hallmark in many tumors (8,9). Recently, hypomethyla-
tion of repetitive elements was demonstrated to be highly
associated with cancer progression and poor clinical
outcome (10–12). Rather than being a passive bystander,
repetitive elements may play a critical role in the establish-
ment of genome-wide methylation patterns. In the past
decade, homology dependent methylation has been
found to be a mechanism that initiates de novo DNA
methylation and transmits methylation patterns. DNA
methylation has been proposed to result from homologous
DNA:DNA or DNA:RNA pairings (13,14). Both types of
pairings have been observed with repetitive elements,
which may serve as methylation ‘way stations’ (15–17).
Recently, AluY/S elements were shown to be enriched at
the junction between hypermethylated and hypomethy-
lated genomic regions (18). Thus, epigenetic analyses
of repetitive elements will contribute signiﬁcantly to our
understanding of the dynamics of DNA methylation in
the human genome.
Numerous approaches have been developed for
genome-wide methylation analysis (19). These
approaches can be classiﬁed into three major categories:
restriction enzyme-based, microarray-based and bisulﬁte
sequencing-based (18–21). Data generated with methyla-
tion-sensitive restriction enzymes are limited to the recog-
nition sites of the enzymes used. Microarray-based
methods for methylation proﬁling have limitations, not
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among members of repetitive DNA families. Sequencing
of bisulﬁte-treated DNA is thus still considered as the gold
standard for high-resolution DNA-methylation proﬁling.
By bisulﬁte-sequencing speciﬁc loci, Beck and colleagues
determined the methylation proﬁle of over 0.1% of the
human epigenome in normal and in disease tissues (20).
Although this provided a great deal of information, it
cannot be conveniently scaled up. Recently, shotgun
sequencing of bisulﬁte-converted genomic DNA has
been exploited to generate an epigenomic map for
Arabidopsis (22,23). Furthermore, ‘reduced representation
bisulﬁte sequencing’ has been proposed for large-scale
analysis of epigenomes of greater complexity (24,25).
However, mapping of short sequence reads obtained
from bisulﬁte converted genomic DNA remains challeng-
ing, most especially when derived from repetitive
sequences. Besides a recent eﬀort to track hypomethylated
Alu elements in normal and in cancer cells (26), no high-
throughput method has been reported to date for genome-
wide ascertainment of the status of CpG methylation of
repetitive elements and their ﬂanking sequences.
Here we report a strategy to amplify and sequence large
sets of repetitive elements and their ﬂanking sequences,
from bisulﬁte converted genomic DNA. Using this
approach, we generated a methylation map of Alu ele-
ments in normal human cerebellum.
METHODS
The generation of a nucleotide position weight matrix for
Alu elements
The human genome sequence (build36/hg18, March 2006)
and the annotated Alu repetitive elements were obtained
from the UCSC Genome Database (27). Considering
genomic coordinates provided by UCSC database,
1180972 Alu sequences were extracted. Consensus
sequences of 32 Alu subfamilies were downloaded from
RepBase (28). For each Alu element and the consensus
sequences, in silico bisulﬁte treatment was performed by
converting CpG dinucleotides in consensus sequences to
YG dinucleotides, and all other Cs—not in CpGs—to Ts.
Together with 32 consensus sequences, multiple sequenc-
ing alignments were conducted for each Alu element using
CLUSTALW (29). To keep track of over one million
alignment results, the consensus sequence derived from
multiple sequence alignment of the 32 Alu subfamilies
was used as reference. In other words, the consensus
sequence was used as a standard to provide coordinates
for each base along the Alu sequences. Primers with spe-
ciﬁcity to a particular subset of Alu repeats were identiﬁed
using this matrix, upon comparison of nucleotide occur-
rences in the given subset of Alu sequences with those in
the remainder Alu elements.
DNA samples
Human genomic DNA samples for fetal adrenal gland
tissues were purchased (BioChain Inc., Hayward, CA).
Human snap-frozen cerebellum and cortex tissues were
obtained from the tissue bank of the Department of
Pathology, Children’s Memorial Hospital at Chicago
under an IRB-approved protocol. Genomic DNA was
extracted with Qiagen DNeasy tissue kit (Qiagen,
Valencia, CA).
Construction and sequencing of repeat amplicon library
Genomic DNA digestion, dephosphoration and
ligation. One microgram of genomic DNA from cerebel-
lum derived from an individual was digested with AluI
restriction enzyme at 378C for 2h, followed by calf intes-
tinal alkaline phosphatase (CIP) incubation at 378C for
1h. The dephosphorylated genomic DNA was mixed
with 100-fold molar excess adaptors in the presence of
T4 DNA ligase at 148C for 12h. The AluI restriction
enzyme, alkaline phosphatase and T4 DNA ligase were
purchased from New England BioLabs, Inc., Beverly,
MA. The adaptors that we utilized were: 50PO4-GAA
GAT GAG TCA GGT CGG CAT CG (30ddC)-3OH0
and 50OH-GCG ATG CCG ACC TGA CTC ATC
TTC-30OH. To remove free adaptors, the ligation product
was puriﬁed with PureLink PCR Puriﬁcation kit
(Invitrogen, Carlsbad, CA).
Bisulfite treatment and PCR. Bisulﬁte modiﬁcation of
genomic DNA was performed with EZ DNA
Methylation Gold kit (Zymo Research, Orange, CA)
according to the manufacturer’s instructions. Brieﬂy,
0.5mg genomic DNA was bisulﬁte-treated, eluted with
10ml elution solution, and stored at –208C until ready
for use. A 50ml PCR mixture was prepared with 2ml
(100ng) bisulﬁte treated DNA, 50pmol each forward
and reverse primers. The sequence of the primer utilized
for annealing to the bisulﬁte converted Alu elements was:
50-GCC TCC CTC GCG CCA TCA GTG TTA GTT
AGG ATG GTT T-30. The sequence of the primer utilized
for annealing to the bisulﬁte converted adaptor was:
50-GCC TTG CCA GCC CGC TCA GCC AAC CTA
ACT CAT CTT C-30. Both PCR primers were fusion pri-
mers containing sequences required for 454 sequencing (in
bold print). The PCR reactions were performed with the
high ﬁdelity PCR master system (Roche Molecular
Systems, Inc., Indianapolis, IN). After denaturation at
948C for 3min, PCR cycles were performed under the fol-
lowing conditions: 948C for 15s, 608C for 30s and 728C
for 1min for three cycles, followed by 948C for 15s and
728C for 1min for 25 additional cycles. PCR products
were ﬁrst puriﬁed with PureLink PCR Puriﬁcation
kit (Invitrogen, Carlsbad, CA) and AMPure beads
(Agencourt Bioscience Corporation, Beverly, MA) to
remove short PCR products. The puriﬁed PCR products
were then stored at 48C until ready for 454 sequencing.
454 sequencing. Total 454 sequencing was conducted with
the Roche Genome Sequencer FLX System. Brieﬂy, after
size selection and quantiﬁcation, PCR products were
annealed to an excess of DNA capture beads and used
as templates for bead-based emulsion PCR. The emulsion
PCR was performed with emPCR Kit II (Amplicon A) to
ensure that subsequent sequencing would be initiated at
the end with the Alu speciﬁc primer. The DNA-containing
capture beads and PCR reagents were emulsiﬁed in
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reactions were performed according to manufacturer’s
instructions. After PCR, the microreactors were then
broken to recover the beads. The beads with PCR pro-
ducts were further enriched and subjected to sequencing.
The amplicon library was sequenced at the Sequencing
Core Facility of the Children’s Memorial Research
Center of Northwestern University’s Feinberg School of
Medicine.
Processing the sequence reads
Sequence mapping. Raw sequencing images were ﬁrst
analyzed with the full data analysis pipeline provided by
the Genome Sequencer FLX System. To identify the geno-
mic origin of the sequence reads, a multistep mapping
procedure was implemented with perl scripts. Since the
sequences were derived from bisulﬁte converted DNA,
an artiﬁcial reference genome database was developed
to host the human genome sequence after in silico bisulﬁte
conversion. More speciﬁcally, the cytosines were con-
verted to thymidines in both strands of each of the chro-
mosomes. In addition, we applied the same conversion to
all sequence reads that we generated.
After removal of primer and adaptor sequences,
sequences  40bp were aligned to the reference genome
using MegaBLAST. To facilitate the alignment procedure
and to increase alignment stringency, multiple cycles
of MegaBLAST were employed. The word size used
in Megablast was set to 100 for the ﬁrst cycle, it was
decreased by 20 for every cycle thereafter till the last, for
which the minimum length of best perfect match was set
to 40. In addition, the identity percentage cutoﬀ for a
signiﬁcant alignment was set to be 100 for the last cycle
and 95 for all other cycles of Megablast. To ensure map-
ping accuracy, sequences that mapped to more than one
position with similar scores (the diﬀerences in E-value are
typically within 100-fold) were removed.
Determination of CpG methylation. To obtain methylation
information and estimate bisulﬁte conversion rate, com-
parisons between sequences generated and corresponding
genomic sequences were conducted. Before sequence
alignment with CLUSTALW, all cytosines in correspond-
ing genomic sequences were converted to thymidines
in silico, except for the ones in CpGs. However, no con-
version was applied to the sequence reads that we gener-
ated. The ﬁnal methylation data were extracted by perl
scripts that we wrote, and stored in two ﬁles of Generic
Feature Format (GFF). One corresponds to the methyla-
tion status of each CpG dinucleotide in the reads, and the
other to the methylation level of each read.
Data integration and visualization
Human genome sequence data and annotations for
repetitive elements and known genes were obtained from
the UCSC Genome Database (30). The coordinates of
putative transcription start sites for known genes were
extracted from the UCSC annotation database. A
MySOL database was designed and implemented to host
the methylation data. At the same time, the database is
also hosting publicly available datasets from several
genome-wide methylation studies, gene expression studies
and annotations for SNPs, genes, CpG islands and Alu
elements. The structure of this database allows integration
of these diﬀerent types of data. On top of the database, a
genome browser was developed to allow synchronic
view of genetic/epigenetic features (http://cmbteg.
childrensmemorial.org/cgi-bin/gbrowse/btech/). With the
genome browser, users can navigate genomic regions
and search for data and annotations available for these
regions. All the data that are populated in the database
can be displayed on the genome browser. The genome
browser installed locally was derived from the building
blocks provided by The Generic Model Organism
System Database Project (31). All perl scripts implement-
ing primer design, sequence processing and mapping in
this study are available upon request.
Pyrosequencing verification
Nested PCR reactions were adopted to amplify the target
regions from bisulﬁte modiﬁed genomic DNA. Two runs
of PCR reactions were carried out using the Hotstart Taq
polymerase kit (Qiagen, Valencia, CA) in 25ml total
volume and with 50pmol each of forward and reverse
primers. In the ﬁrst PCR reaction, 50ng of the bisulﬁte
converted DNA was used as template. After 5min of ini-
tial denaturation at 958C, the cycling conditions of 40
cycles consisted of denaturation at 958C for 15s, anneal-
ing at 558C for 30s and elongation at 728C for 30s. One
microliter of PCR product from the ﬁrst run was used as
template for the second PCR reaction, which after initial
denaturation at 958C for 5min comprised 40 cycles with
denaturation at 958C for 15s, annealing at 558C for 30s
and elongation at 728C for 15s. The PCR products were
stored at 48C until ready for pyrosequencing.
Pyrosequencing was performed using the PyroMark
MD Pyrosequencing System (Biotage, Charlottesville,
VA). The ﬁnal PCR product was puriﬁed using streptavi-
din-Sepharose HP beads (GE Healthcare, Uppsala,
Sweden) and processed to yield single-stranded DNA.
The single-stranded DNA was prepared for pyrosequenc-
ing using the PyroMark Vacuum Prep Tool (Biotage,
Charlottesville, VA). In brief, the PCR product was
bound onto Sepharose beads. Beads containing the immo-
bilized PCR product were washed, denatured using a
0.2M NaOH solution, washed again and neutralized.
Pyrosequencing primer at a concentration of 0.3mM was
annealed to the puriﬁed single-stranded PCR products at
288C. Methylation quantiﬁcation was performed using the
manufacturer-provided software. The primers used in the
PCR runs and pyrosequencing reactions are shown in
Supplementary Table 2.
RESULTS
Sequencing strategy for methylation analysis of bisulfite
converted repetitive DNA elements
Based on the reference genome sequence (hg18, http://
genome.ucsc.edu/), there are over 28 million CpG dinu-
cleotides in the human genome. Repeat elements contain
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main repeat families, SINEs, LINEs and LTRs, contrib-
ute 27%, 12% and 7% of CpG dinucleotides in the
human genome, respectively. In order to obtain a detailed
methylation proﬁle of repetitive elements, we devised and
implemented the strategy shown in Figure 1. In this strat-
egy, one needs to design primers within the repetitive
elements and one has to identify a methylation insensitive
restriction enzyme that does not have recognition site(s)
between the primer annealing region and the end of
repeats. After digestion with the selected restriction endo-
nuclease, genomic DNA is ligated to an alien adaptor and
treated with bisulﬁte. Using primers speciﬁc for a targeted
group of repeats, a complex amplicon library is generated
and sequenced. It should be emphasized that each read
encompasses repetitive as well as (most often) unique
ﬂanking sequences. Unequivocal mapping of repetitive
elements is therefore enabled by their unique ﬂanking
sequences.
In the human genome,  1.2 million Alu elements
belong to the SINE superfamily altogether encompassing
in excess of 7.1 million CpG dinucleotides, which corre-
spond to over 25% of all CpGs in the genome. Therefore,
Alu elements were prioritized for epigenomic analysis in
this study. The consensus sequences of Alu subfamilies
indicate that all Alu subfamilies are rich in CpG dinucleo-
tides (28). However, due to frequent deamination of
methylated cytosines in CpG dinucleotides within Alu
elements, the oldest Alu subfamilies exhibit a signiﬁcant
depletion of CpG dinucleotides (32). We investigated the
preservation of CpG dinucleotides among all Alu subfa-
milies. AluYa-h, the most recent members of the Alu
superfamily, were found to have 28 CpG dinucleotides
on average. In contrast, less than three CpG sites are pres-
ent in AluJ elements, the oldest Alu subfamily. It was also
found that approximately half of all Alu elements have
two or fewer CpGs in their 50 most 80nt.
We identiﬁed 27059 Alu elements that contain seven
or more CpG dinucleotides within their 50 most 80
bases. In order to target the speciﬁc ampliﬁcation of this
subset of Alu elements, a primer design algorithm was
developed and implemented. We determined the nucleo-
tide position weight matrices for all Alu elements and for
the aforementioned selected subset of Alu elements, as
described in the Methods section. The 50 region of Alu
elements contains the A box and the B box promoter
regions of RNA Polymerase III. It is noteworthy that
the 50-terminal region of Alu repeats contains a greater
number of CpG dinucleotides than the 30-end (Figure 2).
Hence, it was targeted for primer design. Comparison of
the two matrices revealed the region from position 82 to
100 in the Alu consensus sequence as the most discrimi-
nating of the selected Alu subset, hence targeted for
primer design (Supplementary Table 1). The lack of
CpG dinucleotides in the primer annealing region ensures
that both methylated and unmethylated Alu elements
(Figure 2) can be ampliﬁed following bisulﬁte treatment.
To select the best suited restriction endonuclease, we
performed in silico genomic DNA digestions of all restric-
tion enzymes with recognition sequences of 4bp and 5bp,
singly and in all combinations. As a result of this analysis,
the restriction enzyme AluI was chosen for this study. The
length of the PCR products derived from the targeted Alu
elements, i.e. those speciﬁcally ampliﬁed with the designed
primer, after digestion of human genomic DNA with
the AluI restriction endonuclease, was in the range of
150–500bp. A critical issue in our approach is the speciﬁ-
city of PCR ampliﬁcation. Due to the high sequence sim-
ilarity among Alu elements, a low annealing temperature
during PCR would lead to non-speciﬁc ampliﬁcation of
undesired Alu elements. In contrast to ‘degenerate’ PCR,
we used the designed primer and conducted PCR under
very stringent conditions. Accordingly, a series of PCR
ampliﬁcations was performed to determine the optimal
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Figure 1. Diagram of experimental design. Genomic DNA is ﬁrst digested with a methylation insensitive enzyme, ligated to adaptors and then
subjected to bisulﬁte treatment. Bisulﬁte treated DNA is ampliﬁed with adaptor and primer speciﬁc for the targeted repeat elements. PCR products
contain repeat sequence and ﬂanking unique genomic sequence. Lastly, the repeat-containing amplicon library thus constructed is subjected to large-
scale sequencing. The methylated cytosines are indicated with the ﬁlled circles while the unmethylated cytosines are indicated with the open circles.
The green and red segments represent the repeat elements with the red segment indicating the region to which the primer anneals. The adaptors are
indicated by blue boxes.
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yield products, which was found to be 608C.
Statistics of the reads and CpG sites sequenced
An amplicon library was constructed from bisulﬁte treated
human cerebellum DNA derived from a single individual,
using the primer, restriction enzyme and annealing
temperature discussed above. A total of 48839943nt
sequences were generated from the amplicon library
using the Roche Genome Sequencer FLX
TM 454 system.
After removal of primer and adaptor sequences, a total of
370612 sequence reads comprising 37011779 bases, with
an average of 100bp per read, were obtained. Sequence
mapping was conducted as described in the ‘Methods’
section (Supplementary Figure 1). Prior to sequence
mapping, all cytosines in the sequence reads and in
the reference human genome sequence were converted to
thymidines in silico. Thus, the methylation variability
and incomplete bisulﬁte conversion would not aﬀect the
accuracy of sequence mapping.
A total of 245825 sequence reads encompassing a total
of 28650038 bases were mapped to 31871 non-overlap-
ping genomic regions. These non-overlapping genomic
regions cover 4223824 bases in the human genome.
The overall mapping eﬃciency was 66% (245825/
370612) and it increases for the longer sequence reads
(Supplementary Figure 2). Based on the comparisons of
mapped sequence reads and the corresponding genomic
sequences, the bisulﬁte conversion rate in this study was
estimated to be 99.1%. The average coverage of each
targeted region was found to be  7-fold (28650038/
4223824). The cluster size distribution of sequences that
could be unequivocally mapped to the genome is shown in
Supplementary Figure 3. Of the 31871 sequence clusters,
38% contained only one sequence read and 95% of all
clusters had fewer than 32 sequence reads. This indicated
that the amplicon library obtained from a single ampli-
ﬁcation was of high complexity. In addition, we also
examined the speciﬁcity of ampliﬁcation. Of the 245825
sequences that were successfully mapped to the genome,
94% were derived from 31178 distinct Alu elements
(Table 1). Over 86% of all sequences generated were
mapped to genomic loci with sequence, after bisulﬁte con-
version, 100% identical to the PCR primer designed.
Once mapped, sequences were compared to the refer-
ence human genomic sequence. With respect to methyla-
tion, 1252562 methylation data points were obtained
from 159225 distinct CpG sites. On average, ﬁve CpG
Table 1. Statistics of Alu elements sequenced
Alu sub
family
Number of Alu elements
in genome
Number of distinct
Alu elements sequenced
Number of sequences
generated
Precentage of
sequences generated
a
AluY 137925 23857 207602 84.5
AluSc 49325 1725 7365 3.0
AluSx 339002 1438 2744 1.1
AluSg 81915 1304 4381 1.8
AluYa_h
b 9646 672 3494 1.4
AluJb 128539 539 1044 0.4
AluJo 141841 510 806 0.3
AluSq 94487 450 926 0.4
AluSp 50917 231 467 0.2
Others 147375 452 1218 0.5
Total 1180972 31178 230047 93.6
aThe percentage was calculated as the number of sequences from Alu subfamily divided by the total number of sequences mapped (245825 sequence
reads).
bAluYa-h denotes the young AluY families: AluYa to AluYh.
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methylation statuses of 0.6% of all CpG dinucleotides
found in the human genome were determined in this
study. The genomic distribution of the CpG dinucleotides
sequenced in this study was further examined. For each
chromosome, the ratio of the number of CpG dinucleo-
tides sequenced to the total number of CpG dinucleotides
in the chromosome was calculated (Supplementary
Figure 4A). This ratio varied in the 0.5–0.8% range
across chromosomes. Since Alu elements are known to
be co-localized with genes (33), the chromosomes rich in
genes, such as chr19, are the ones with the highest percent-
age of CpG dinucleotides sequenced. The CpG dinucleo-
tides sequenced in this study were widely distributed
within each chromosome (Chr1 is shown as example in
Supplementary Figure 4B). This demonstrated that, with
a single primer, we could target thousands of CpG dinu-
cleotides simultaneously in a genome-wide manner.
Alu methylation profile in human normal cerebellum
It has been well known that human Alu elements are heav-
ily methylated in normal tissues, including brain (34).
However, the genome-wide pattern of Alu methylation
remains unknown due to the lack of an eﬃcient methodol-
ogy. To obtain a comprehensive understanding of the
methylation data generated in this study, we assessed the
methylation data at four levels: sequence reads, sequence
read clusters, all methylation values obtained and the
methylation of CpG sites (the clusters of methylation
values). We found that 75.1% of all reads were found to
be completely methylated and less than 2% of reads were
completely unmethylated. After the reads were clustered,
43.5% of the 31871 read clusters were completely methy-
lated and 3.6% were completely unmethylated. In terms
of individual methylation data points, 93.5% of the 1.2
million methylation data points generated were found to
be methylated. Once these methylation values were
assigned to individual CpG sites, 76.2% of 159225 distinct
CpG sites sequenced were always methylated and 7.4%
were always unmethylated while the remainder showed a
mixed methylation pattern.
To further understand the underlying mechanisms
controlling the methylation of the 50-end and ﬂanking
sequences of Alu elements, we examined the methylation
levels of CpG sites with respect to their genomic localiza-
tion (Table 2). The methylation levels of CpG sites in
introns, 30 UTRs and in intergenic regions were  94%.
The methylation levels of CpG sites in coding regions,
in 50UTRs and within 1kb from transcription start sites
(as indicated in the UCSC Genome Database) were
79.2%, 82.8% and 84.2%, respectively. We further exam-
ined the methylation statuses of 6477 CpG sites that
mapped within  2kb of the TSSs of 1081 known genes.
We found that methylation levels decreased the closer
the CpG dinucleotides were to the TSSs, and that they
in turn increased symmetrically the farther they were
to the TSSs (Figure 3A). In addition, we observed that
the unmethylated CpG sites identiﬁed in our study
tended to be in clusters. We then examined the methyla-
tion levels of CpG sites adjacent to 11740 unmethylated
CpG dinucleotides. Signiﬁcantly less methylation was
observed within 200–300bp from an unmethylated CpG.
Furthermore, we found that such a correlation deterio-
rates rapidly after 300bp (Figure 3B).
A recent study tracking hypomethylated Alus identiﬁed
59 hypomethylated Alu elements in normal colonic
mucosa (26). In that study, based on a simulation, 4104
Alu elements (2.6% of all Alu elements) with sequence AA
CCCGGG were predicted to be unmethylated or partially
unmethylated. In our study, excluding the sequence reads
without CpG dinucleotides, 1690 clusters derived from
Alu elements ( 5% of all sequenced) were found to con-
tain at least one completely unmethylated read. To further
understand the methylation pattern of Alu repeats, the
family distribution of unmethylated Alu elements was
examined (Supplementary Table 3). Only 1.6% of very
recent Alu elements (AluYa-h) were found to have com-
pletely unmethylated reads, while over 20% of the oldest
Alu subfamily (AluJb) were found to have completely
unmethylated reads. Such signiﬁcant enrichment for
unmethylated CpGs in old Alu subfamilies suggested
that the oldest Alu elements (AluJb and AluJo),
with fewer CpG sites in avereage and mutated RNA
Polymerase III promoter regions, are more likely to be
completely unmethylated.
As an independent approach, pyrosequencing was
used to verify the methylation data generated. Since
most of Alu elements are heavily methylated, a successful
veriﬁcation for hypermethylated Alus could be achieved
simply by chance. To maximize the power of validation,
we focused on the Alu elements identiﬁed to be hypo-
methylated based on the 454 sequencing results. Ten dif-
ferent hypomethylated loci with various numbers of 454
sequence reads generated and diﬀerent levels of methyla-
tion were selected (Supplementary Table 4). Of the ten loci
examined, nine were conﬁrmed to exhibit a low level of
methylation, including two loci for which only two 454
sequence reads were available (Figure 4A). The remaining
one locus showed a signiﬁcant level of methylation (61.9).
It is noteworthy, however, that there was a single 454
sequence read available for this locus. For all 54 CpG
Table 2. The average methylation level of CpG clusters with diﬀerent
genomic localization
Number of
methylation
value
Number of
distinct CpG
dinucleotides
Methylation
level
Within 1kb
upstream from
TSSs
a
11185 1437 84.2
50UTR 586 135 82.8
CDS 857 187 79.2
30UTR 5082 687 93.3
Intron 443817 58718 93.5
Intergenic
b 791035 98061 93.6
SUM 1252562 159225
aTSSs denotes Transcription Start Sites.
bThe genomic regions within 1-kb upstream from TSSs were excluded
from intergenic regions.
4336 Nucleic Acids Research, 2009, Vol. 37,No. 13sites veriﬁed, the methylation levels varied from 1% to
72%, with an average of 15% (Supplementary Table 4).
Considering that 93.5% of the methylation data points
generated in this study was methylated, these pyrosequen-
cing results strongly indicate that the 454 sequence data
herein reported are reliable.
Tissue-specific Alu methylation
Recently, Ladd-Acosta et al. (35) examined the methyla-
tion proﬁles of 1505 CpG sites representing 807 genes
in diﬀerent brain regions. At least 20 CpG sites were
shown to be diﬀerentially methylated in matched cerebel-
lum and cortex. To determine whether Alu elements might
also exhibit a brain-region-speciﬁc methylation pattern,
we investigated the methylation proﬁles of a few hypo-
methylated Alu elements, which are adjacent to pro-
moters, in paired cerebellum and cortex tissues from
seven individuals and in fetal adrenal gland tissues from
seven other individuals. Interestingly, the Alu elements
demonstrated very distinct methylation proﬁles
(Figure 4B). Locus 1 and Locus 6 seem to be tissue-
speciﬁcally methylated. Locus 1 localizes in the intron of
the Fem-1 homolog b gene at a distance of 3kb from the
promoter. The average methylation levels of Locus 1 are
31% in cerebellum, 79% in cortex and 61% in fetal adre-
nal gland. Locus 6 is in the 30-UTR of the telomeric repeat
binding factor 2 gene,  5kb away from the promoter of
the downstream gene, which codes for the transmembrane
emp24 protein. The average methylation levels of Locus 6
are 32% in cerebellum, 86% in cortex and 92% in fetal
adrenal gland. Both locus 5 and locus 9 were found to
exhibit a low level of methylation in all samples examined.
Locus 5 localizes in the intron of the A2ML1 gene at a
distance of 4kb from an alternative promoter, while locus
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Figure 3. The methylation proﬁle of CpG sites sequenced. (A) CpG methylation near transcription start sites (TSSs). The X-axis represents the
distance of CpG sites sequenced to the TSSs. The Y-axis represents the average methylation level. The average methylation levels were calculated
for CpG sites adjacent to TSSs in 100-bp increments. (B) Spatial methylation correlation surrounding unmethylated CpG sites. The X-axis represents
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Nucleic Acids Research, 2009,Vol.37, No. 13 43379 is located 300bp from a CpG island that overlaps with
the promoter of the transmembrane protein 183A gene.
Based on microarray, SAGE and EST data provided by
GeneCards (http://www.genecards.org/), all the genes
adjacent to the unmethylated Alu elements herein investi-
gated are expressed in cerebellum. Additional studies
will be required to investigate the signiﬁcance of the
unmethylated status of these Alu elements to the expres-
sion of the nearby genes.
To visualize the methylation data reported in this study,
a genome browser has been developed and installed at
http://cmbteg.childrensmemorial.org/cgi-bin/gbrowse/
btech. This genome browser integrates the methylation
data that we generated with publicly available data on
repeat elements, CpG islands, gene structure and other
genomic features. A representative screen of this browser
is shown in Supplementary Figure 5. In addition, we have
collected several sets of genome-scale DNA-methylation
data, including the methylation data for over 2500 geno-
mic loci determined by Human Epigenome Consortium
(20). More detailed descriptions of all datasets were pro-
vided on the website. Although the direct comparison of
these datasets could be challenging due to the diﬀerences
in tissue samples studied and techniques used, the genome
browser may enable the researchers to examine the details
of methylation proﬁles for speciﬁc genomic loci.
DISCUSSION
The determination of a complete DNA-methylation
proﬁle of the human genome, the methylome, will further
our understanding of the human epigenome and of its
functional signiﬁcance. Bisulﬁte sequencing is the best
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proﬁles of four loci adjacent to promoters in cerebellum, cortex and fetal adrenal gland. The X-axis represents the distinct tissue sample IDs. CE,
CO and AG represent the cerebellum, cortex and fetal adrenal gland tissues, respectively. Paired cerebellum and cortex were shown with the same
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4338 Nucleic Acids Research, 2009, Vol. 37,No. 13approach to generate methylome data at a single base res-
olution (20,22–24). However, limited bisulﬁte sequencing
data have been generated for the human genome to date.
We have developed a bisulﬁte-based sequencing strategy
targeting the methylome of Alu repeats and their ﬂanking
sequences. Using a single Alu speciﬁc primer, we simulta-
neously ampliﬁed thousands of Alu elements and obtained
over 1.2 million methylation data points for 31871 geno-
mic regions, 94% of which were derived from the 50 end
regions and 50 ﬂanking sequences of Alu elements. The
high sequence complexity and target speciﬁcity of the
amplicons thus produced make them invaluable as epigen-
ome representations, in studies aimed at uncovering epi-
genomic alterations associated with normal development
and disease. Accordingly, it is noteworthy that we have
successfully utilized this approach to monitor epigenomic
alterations in non-aggressive and aggressive pediatric
ependymomas, based on the methylation statuses of a
common set of  100000 CpGs (Xie, H. and Soares,
M.B., data not shown).
In our study, only a small subset of a million Alu ele-
ments was sampled. Since the primer used was designed
for Alu elements rich in CpG dinucleotides, this study is
biased for younger Alu elements. To scale up the coverage,
primers targeting diﬀerent sets of Alu elements could be
designed with a similar approach. On the other hand, this
study covered a signiﬁcant number of genomic loci,
although the number of sequence reads generated was
not enough to provide deep read coverage for all loci.
Thus, the result for individual CpG sites or locus without
deep read coverage should be taken cautiously. To
increase the read coverage and reduce the sequencing
cost, this approach may be modiﬁed for pair-end sequen-
cing or to target hypomethylated Alu elements alone. In
addition, the digestion with AluI enzyme releases various
lengths of fragments and the shorter ones were ampliﬁed
in much higher eﬃciency. To reduce such PCR bias, linear
ampliﬁcation should be explored in the future.
Despite the limitations discussed above, some interest-
ing observations were made in our study. By examining
the methylation patterns of 17 diﬀerent LINE-1 elements,
Phokaew et al. (36) demonstrated that the LINE1 methy-
lation can be inﬂuenced diﬀerentially depending on their
genomic locations. We found that the methylation statuses
of CpG dinucleotides that occur within the 50 most 80
bases of Alu elements can also be entirely diﬀerent
even though their sequences may be nearly identical,
thus indicating that the methylation levels of Alu elements
are not simply determined by their sequences either. The
CpG sites sequenced in our study were 10% more methy-
lated in intergenic, intronic and 30 untranslated regions
than in promoters, 50-UTRs and coding regions.
Although our dataset is very diﬀerent from the data gen-
erated by the Human Epigenome Consortium (20), we
also found that the methylation level is low in the regions
close to transcription start sites and that it increases sym-
metrically with distance from TSSs. In addition, less
methylation was observed within 200–300bp of an
unmethylated CpG and such co-methylation eﬀect dete-
riorated with distance. With pyrosequencing, we were
able to verify the methylation patterns of a small set of
hypomethylated Alu elements. More interestingly, our
result suggested that some Alu elements might be tissue
speciﬁcally methylated.
Dynamic DNA methylation, particularly in repetitive
elements, has been shown during normal development
and disease progression (2,37–39). As mentioned pre-
viously, AluY/S elements were shown to be enriched at
the junction of hypermethylated and hypomethylated
genomic regions (18). Hence, Alu elements may serve as
sensors for DNA-methylation changes. Therefore, it
would be interesting to use the approach outlined in this
article to study the methylation diﬀerences not only
among diﬀerent tissues but also within the same tissue at
diﬀerent stages of development, as well as during disease
progression. This approach will enable monitoring of the
methylation status for a speciﬁc subset of Alu elements
and will contribute signiﬁcantly to the understanding of
the dynamics of DNA methylation. In addition, the loss of
DNA methylation in the genome of cancers was found
to be associated with genome instability. Accordingly,
it is noteworthy that the sequence-based strategy herein
described, while producing methylation data, can also
reveal associated structural alterations, such as insertions
and deletions. Additionally, the strategy outlined in this
study could be adapted to study the epigenome of other
model organisms.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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